Liangfang Shen
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Topics
- RNA modifications and cancer (9 papers)MicroRNA in disease regulation (8 papers)Cancer-related molecular mechanisms research (8 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Liangfang Shen
76 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 946
- Cancer Research 598
- Oncology 390
- Pulmonary and Respiratory Medicine 202
- Immunology 131
Countries citing papers authored by Liangfang Shen
This map shows the geographic impact of Liangfang Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangfang Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangfang Shen more than expected).
Fields of papers citing papers by Liangfang Shen
This network shows the impact of papers produced by Liangfang Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangfang Shen. The network helps show where Liangfang Shen may publish in the future.
Co-authorship network of co-authors of Liangfang Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Liangfang Shen. A scholar is included among the top collaborators of Liangfang Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangfang Shen. Liangfang Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 26 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | 3 | |
| 9 | 14 | |
| 10 | 9 | |
| 11 | 1 | |
| 12 | 11 | |
| 13 | 4 | |
| 14 | 45 | |
| 15 | 1 | |
| 16 | 6 | |
| 17 | 13 | |
| 18 | 33 | |
| 19 | 9 | |
| 20 | 25 |
About Liangfang Shen
Liangfang Shen is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 77 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (390 citations) and Molecular Biology (946 citations). Liangfang Shen has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Xinqiong Huang, Jun Fu, Lin Shen, Fujun Li, Junwen Yang, Yanyan Li, Chaojun Duan, Xiaoxue Xie, Zhanzhan Li and Yan Xu. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.